The Pacific Research Institute has issued a report arguing that American patients would benefit from an FDA that does not have a monopoly on regulation for health care treatments.
Instead, the think tank argues that “allowing American patients to access EU-approved medicines would enable more patient choice and potentially save the lives of those suffering illnesses with no available treatment options.”
The report uses data regarding FDA & EMA approval rates & evaluation periods to make its case. “Clearly,” the think tank argues, “Congress’s grant of a regulatory monopoly to the FDA is creating a significant obstacle to Americans’ timely access to new medicines.”
Good idea or obvious compromise to safety?
